 |
| Photo by PR Photos |
Hair loss is one of the most noticeable side-effects of chemotherapy treatment, but a new treatment may be able to help.
US Oncology Research and Baylor College of Medicine have launched a clinical trial to test the Orbix Paxman Hair Prevention System's efficacy at reducing or altogether stopping chemotherapy-induced hair loss. The treatment uses a lightweight silicone cap with a special coolant that is placed on the scalp 30 minutes before and 90 minutes after each chemotherapy session.
For more information, visit this link.
No comments:
Post a Comment